Dravet syndrome (DS), previously known as severe myoclonic epilepsy of infancy, is a
severe developmental and epileptic encephalopathy caused by loss-of-function mutations in …

Introduction Dravet syndrome (DS), a prototypic developmental and genetic epileptic
encephalopathy (DEE), is characterized by an early onset of treatment-refractory seizures …

Dravet syndrome (DS), also known as severe myoclonic epilepsy of infancy (SMEI), is one of
the rare early childhood intractable epileptic encephalopathies associated with pleomorphic …

Dravet Syndrome (DS) is a developmental epileptic encephalopathy characterized by drug-
resistant seizures and other clinical features, including intellectual disability and behavioral …

ABSTRACT Introduction Dravet Syndrome (DS) is a developmental and epileptic
encephalopathy carrying high-level psychobehavioral burdens. Although the disease has …

Dravet syndrome (DS) is a severe, rare, and complex developmental and epileptic
encephalopathy affecting 1 in 16 000 live births and characterized by a drug‐resistant …

Dravet syndrome (DS) is an intractable pediatric epilepsy syndrome, starting in early
childhood. This disorder typically manifests with febrile status epilepticus, and progresses to …

Dravet syndrome is a debilitating epileptic encephalopathy of childhood with few treatment
options available in the United States before 2018. In the modern era, new genetic testing …

Dravet syndrome (DS), previously known as severe myoclonic epilepsy in infancy (SMEI), is
an epileptic encephalopathy that presents with prolonged seizures in the first year of life …

Dravet syndrome (DS) is a form of genetic refractory epilepsy. More than 80% of DS patients
carry pathogenic SCN1A mutations, and this percentage is actually higher due to false …